Advice

in the absence of a submission from the holder of the marketing authorisation

tigecycline (Tygacil®) 50 mg powder for solution for infusion is not recommended for use within NHS Scotland.

Indication under review: Treatment in children from the age of eight years for the following infections:
• complicated skin and soft tissue infections, excluding diabetic foot infections
• complicated intra-abdominal infections

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Download detailed advice62KB (PDF)

Download

Medicine details

Medicine name:
tigecycline (Tygacil)
SMC ID:
1101/15
Indication:
Treatment in children from the age of eight years for the following infections: complicated skin and soft tissue infections, excluding diabetic foot infections complicated intra-abdominal infections
Pharmaceutical company
Pfizer Ltd
BNF chapter
Infections
Submission type
Non submission
Status
Not recommended
Date advice published:
07 September 2015